Trident Lifeline Share Price
417.00+0.00 (+0.00%)
+40.64% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
TLL-MNSE
Trident Lifeline Share Price
417.00+0.00 (+0.00%)
+40.64% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 60% | 48% |
| - | - | 47% | 84% |
| - | - | 30% | 41% |
| 33% | 33% | 19% | 25% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
LAURUSLABS-A
ZYDUSLIFE-A
DRREDDY-A
CIPLA-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
TLL-M
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,784.1 | ₹425150 Cr | 38.77 | 8.29 | 58.23 | ₹11479 Cr |
| 9,998.35 | ₹266265 Cr | 91.03 | 34.04 | 128.41 | ₹2568 Cr |
| 4,638.6 | ₹176301 Cr | 83 | 14.04 | 106.21 | ₹2163 Cr |
| 2,316.2 | ₹125352 Cr | 93.56 | 8.17 | 33.94 | ₹889 Cr |
| 1,257.15 | ₹123591 Cr | 27.39 | 9.42 | 62.53 | ₹5040 Cr |
| 1,371.65 | ₹114351 Cr | 40.84 | 11.08 | 59.2 | ₹4196 Cr |
| 1,395 | ₹112474 Cr | 38.82 | 10.86 | 52.6 | ₹3879 Cr |
| 2,486.05 | ₹102315 Cr | 45.62 | 17.23 | 76.26 | ₹1913 Cr |
| 1,695.85 | ₹97757 Cr | 26.33 | 17.95 | 96.84 | ₹3505 Cr |
| 2,022.55 | ₹92007 Cr | 16.64 | 30.95 | 154.35 | ₹5333 Cr |
| 417 | ₹500 Cr | 26.24 | 5.52 | 20.96 | ₹19 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹47 Cr | ₹34 Cr | ₹26 Cr | ₹31 Cr | ₹24 Cr | ₹12 Cr | ₹15 Cr | ₹13 Cr | ₹7 Cr | ₹5 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹6 Cr | ₹9 Cr |
| ₹97 L | ₹57 L | ₹5 Cr | ₹2 Cr | ₹1 Cr | ₹56 L | ₹54 L | ₹1 Cr | ₹25 L | ₹38 L | ₹33 L | ₹64 L | ₹39 L | ₹90,000 | ₹17 L |
| ₹48 Cr | ₹34 Cr | ₹30 Cr | ₹33 Cr | ₹25 Cr | ₹12 Cr | ₹16 Cr | ₹14 Cr | ₹7 Cr | ₹5 Cr | ₹9 Cr | ₹9 Cr | ₹10 Cr | ₹6 Cr | ₹9 Cr |
| ₹37 Cr | ₹27 Cr | ₹23 Cr | ₹25 Cr | ₹20 Cr | ₹8 Cr | ₹12 Cr | ₹11 Cr | ₹6 Cr | ₹5 Cr | ₹7 Cr | ₹7 Cr | ₹8 Cr | ₹5 Cr | ₹7 Cr |
| ₹12 Cr | ₹9 Cr | ₹10 Cr | ₹9 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹2 Cr | ₹43 L | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹87 L | ₹2 Cr |
| ₹2 Cr | ₹86 L | ₹1 Cr | ₹99 L | ₹1 Cr | ₹55 L | ₹50 L | ₹49 L | ₹15 L | ₹9 L | ₹10 L | ₹15 L | ₹13 L | ₹8 L | ₹7 L |
| ₹9 Cr | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹28 L | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹70 L | ₹2 Cr |
| ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹62 L | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹70 L | ₹3 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| — | — | — | — | — |
| ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹8 Cr |
| ₹4 Cr | ₹0 | ₹99 L | ₹0 | ₹0 |
| ₹85 Cr | ₹53 Cr | ₹40 Cr | ₹34 Cr | -₹3 Cr |
| ₹85 Cr | ₹53 Cr | ₹40 Cr | ₹34 Cr | -₹3 Cr |
| ₹100 Cr | ₹64 Cr | ₹53 Cr | ₹46 Cr | ₹5 Cr |
| ₹7 Cr | ₹5 Cr | ₹1 Cr | ₹1 Cr | ₹0 |
| ₹24 Cr | ₹19 Cr | ₹9 Cr | ₹3 Cr | ₹0 |
| ₹16 Cr | ₹13 Cr | ₹4 Cr | ₹1 Cr | ₹1 Cr |
| -₹2 Cr | -₹2 Cr | -₹15 L | -₹52 L | -₹1 Cr |
| ₹7 L | ₹7 L | ₹7 L | ₹7 L | ₹7 L |
| ₹38 Cr | ₹30 Cr | ₹13 Cr | ₹3 Cr | ₹45 L |
| — | — | — | — | — |
| ₹38 Cr | ₹15 Cr | ₹8 Cr | ₹5 Cr | ₹5 Cr |
| ₹16 Cr | ₹19 Cr | ₹7 Cr | ₹4 Cr | ₹1 Cr |
| ₹26 Cr | ₹17 Cr | ₹4 Cr | ₹3 Cr | ₹60 L |
| ₹8 Cr | ₹5 Cr | ₹2 Cr | ₹57 L | ₹51 L |
| ₹88 Cr | ₹55 Cr | ₹21 Cr | ₹12 Cr | ₹8 Cr |
| ₹234 Cr | ₹155 Cr | ₹88 Cr | ₹62 Cr | ₹13 Cr |
| ₹5 Cr | ₹5 Cr | ₹0 | ₹0 | ₹0 |
| ₹73 Cr | ₹54 Cr | ₹18 Cr | ₹8 Cr | ₹2 Cr |
| — | — | — | — | — |
| ₹78 Cr | ₹57 Cr | ₹23 Cr | ₹4 Cr | ₹2 Cr |
| ₹18 Cr | ₹14 Cr | ₹2 Cr | ₹1 Cr | ₹80 L |
| ₹61 Cr | ₹44 Cr | ₹21 Cr | ₹3 Cr | ₹1 Cr |
| ₹17 Cr | ₹2 Cr | ₹4 Cr | ₹5 Cr | ₹0 |
| ₹8 Cr | ₹11 Cr | ₹4 Cr | ₹3 Cr | ₹0 |
| ₹8 Cr | ₹11 Cr | ₹4 Cr | ₹3 Cr | ₹0 |
| ₹2 Cr | ₹1 Cr | ₹4 Cr | ₹85 L | ₹67 L |
| ₹3 Cr | ₹3 Cr | ₹0 | ₹0 | ₹0 |
| ₹91 Cr | ₹61 Cr | ₹33 Cr | ₹12 Cr | ₹2 Cr |
| — | — | — | — | — |
| ₹2 L | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹36 Cr | ₹28 Cr | ₹13 Cr | ₹7 Cr | ₹4 Cr |
| ₹74 Cr | ₹28 Cr | ₹13 Cr | ₹12 Cr | ₹5 Cr |
| ₹4 Cr | ₹2 Cr | ₹7 Cr | ₹14 Cr | ₹16 L |
| ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹9 L |
| ₹24 Cr | ₹32 Cr | ₹18 Cr | ₹14 Cr | ₹2 Cr |
| ₹140 Cr | ₹92 Cr | ₹53 Cr | ₹50 Cr | ₹11 Cr |
| ₹52 Cr | ₹37 Cr | ₹32 Cr | ₹38 Cr | ₹3 Cr |
| ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹67 L | ₹3 L |
| ₹234 Cr | ₹155 Cr | ₹88 Cr | ₹62 Cr | ₹13 Cr |
| ₹79 | ₹54 | ₹43 | ₹39 | ₹6 |
| ₹79 | ₹54 | ₹43 | ₹39 | ₹6 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent of Subsidiaries under liquidations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| ₹27 Cr | ₹14 Cr | ₹9 Cr | ₹7 Cr | ₹3 Cr |
| ₹7 Cr | ₹7 Cr | ₹12 L | ₹8 L | ₹33 L |
| -₹22 Cr | -₹20 Cr | -₹4 Cr | -₹25 Cr | -₹4 Cr |
| ₹13 Cr | ₹56 L | ₹5 Cr | -₹18 Cr | -₹36 L |
| ₹5 Cr | -₹4 Cr | ₹2 Cr | -₹19 Cr | -₹21 L |
| -₹37 Cr | -₹14 Cr | -₹20 Cr | -₹10 Cr | -₹45 L |
| ₹34 Cr | ₹14 Cr | ₹11 Cr | ₹42 Cr | ₹80 L |
| ₹2 Cr | -₹4 Cr | -₹7 Cr | ₹14 Cr | ₹14 L |
| ₹2 Cr | ₹7 Cr | ₹14 Cr | ₹18 L | ₹1 L |
| ₹0 | ₹11 L | ₹0 | ₹0 | ₹0 |
| ₹4 Cr | ₹2 Cr | ₹7 Cr | ₹14 Cr | ₹16 L |
Fundamental Ratios
Consolidated
Standalone
No results found
Trident Lifeline Share Price
417.00+0.00 (+0.00%)
+40.64% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 0 out of 9 oscillators
RSI
58.28Buy
STOCH %K
59.02Neutral
MACD Level(12,26)
16.22Buy
Ultimate Oscillator
54.76Buy
Aroon Oscillator
82.00Buy
BOP
0.00Neutral
CCI
61.98Neutral
Williams %R
-40.98Neutral
Momentum
14.75Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
414.05Buy
SMA 9
418.44Sell
EMA 21
402.02Buy
SMA 21
403.48Buy
EMA 50
366.61Buy
SMA 50
356.20Buy
EMA 200
303.94Buy
SMA 200
286.10Buy
WMA 20
411.30Buy
Pivot
Pivot
Classic
Resistance 5
428.18
Resistance 4
425.13
Resistance 3
422.08
Resistance 2
419.03
Resistance 1
418.02
Pivot
415.98
Support 1
414.97
Support 2
412.93
Support 3
409.88
Support 4
406.83
Support 5
403.78
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Trident Lifeline Share Price
417.00+0.00 (+0.00%)
+40.64% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 62.46% | 62.59% | 62.85% | 64.11% | 63.11% | 63.04% |
| 1.16% | 5.25% | 7.24% | 7.04% | 7.71% | 7.21% |
| 0.21% | 0.26% | 0.27% | 0.35% | 0.41% | 0.39% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 36.17% | 31.90% | 29.64% | 28.50% | 28.77% | 29.36% |
Bulk & block deals
Name
Quarks Technosoft Private Limited
Quarks Technosoft Private Limited
Craft Emerging Market Fund Pcc-Elite Capital Fund
Nav Capital Vcc - Nav Capital Emerging Star Fund
Rinkal Mayurbhai Gajera
Kamal Amar Shah
Prabhat Financial Services Limited
Brimming Wealth Advisors Llp
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 15 Sep 2026 | Purchase | 2.40 Cr | ₹289.34 | 82.80 K | Bulk | 0.701814 | BSE |
| 15 Sep 2026 | Sell | 3.57 L | ₹297.10 | 1.20 K | Bulk | 0.010171 | BSE |
| 15 Sep 2026 | Sell | 2.26 Cr | ₹283.74 | 79.80 K | Bulk | 0.676386 | BSE |
| 15 Sep 2026 | Sell | 2.10 Cr | ₹280.51 | 75 K | Bulk | 0.635701 | BSE |
| 27 Mar 2026 | Sell | 1.58 Cr | ₹263.40 | 60 K | Bulk | 0.508561 | BSE |
| 27 Mar 2026 | Purchase | 2.48 Cr | ₹261.46 | 94.80 K | Bulk | 0.803526 | BSE |
| 23 Jan 2026 | Sell | 2.12 Cr | ₹289.68 | 73.20 K | Bulk | 0.620444 | BSE |
| 23 Jan 2026 | Purchase | 2.26 Cr | ₹289.76 | 78 K | Bulk | 0.661129 | BSE |
Insider trading & SAST
Client name
Hardik Desai Family Trust
Shikha Bafna
Hardik Desai Family Trust
Hardik Desai Family Trust
Shikha Ashish Bafna
Hardik Desai Family Trust
Rinkal Mayurbhai Gajera
Rupaben Jariwala
Amit Halvawala
Amit Halvawala
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 Jul 2026 | Promoter | Acquisition | 0.01 | 7.18 | 0 | — | 1.20 K | 12 Jun 2026 | Market | 8,57,366 | SAST | 29(2) | — |
| 14 Jul 2026 | Other | Acquisition | 0.02 | 0.23 | 0 | — | 3 K | 03 Jun 2026 | Market | 27,600 | SAST | 29(1) | — |
| 14 Jul 2026 | Promoter | Acquisition | 0.08 | 7.15 | 0 | — | 9 K | 29 May 2026 | Market | 8,53,166 | SAST | 29(2) | — |
| 15 Jun 2026 | Promoter Group | Acquisition | 0.010171 | 7.18 | 2.99 L | ₹249 | 1.20 K | 12 Jun 2026 | Market Purchase | 8,57,366 | Insider Trading | — | Equity Shares |
| 04 Jun 2026 | Immediate Relative | Acquisition | 0.025428 | 0.23 | 7.44 L | ₹248 | 3 K | 02 Jun 2026 | Market Purchase | 27,600 | Insider Trading | — | Equity Shares |
| 01 Jun 2026 | Promoter Group | Buy | 0.076284 | 7.15 | 22.39 L | ₹248.82 | 9 K | 29 May 2026 | Market Purchase | 8,53,166 | Insider Trading | — | Equity |
| 26 May 2026 | Promoter | Disposal | 0.5 | 3.48 | 0 | — | 60 K | 27 Mar 2026 | Market | 4,15,010 | SAST | 29(2) | — |
| 26 May 2026 | Promoter | Disposal | 0.23 | 5.3 | 0 | — | 27.60 K | 27 Mar 2026 | Market | 6,31,900 | SAST | 29(2) | — |
| 26 May 2026 | Promoter | Disposal | 0.14 | 0.85 | 0 | — | 16.80 K | 30 Mar 2026 | Market | 1,01,500 | SAST | 29(2) | — |
| 26 May 2026 | Promoter | Disposal | 0.15 | 0.99 | 0 | — | 18 K | 27 Mar 2026 | Market | 1,18,300 | SAST | 29(2) | — |
Trident Lifeline Share Price
417.00+0.00 (+0.00%)
+40.64% past 1 Year
Trident Lifeline Limited is engaged in the pharmaceutical business ethical marketing in domestic as well as international market. It is also engaged in distribution of pharmaceutical products through third party
Corporate Actions
Date
Type
Details
Company details
Trident Lifeline Share Price
417.00+0.00 (+0.00%)
+40.64% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Trident Lifeline Share Price
417.00+0.00 (+0.00%)
+40.64% past 1 Year
News
Trident Lifeline reports Profit after tax of 5.66 Crores, in the March 2026 quarter
Equity
TLL
Trident Lifeline informs about updates
Equity
TLL
Trident Lifeline informs about trading window closure
Equity
TLL
Trident Lifeline reports Profit after tax of 4.02 Crores, in the December 2025 quarter
Equity
TLL
Trident Lifeline rises on acquiring additional stake in Trident Mediquip
Equity
TLL
Trident Lifeline acquires additional stake in Trident Mediquip
Equity
TLL
Trident Lifeline informs about resignation of director
Equity
TLL
Trident Lifeline reports Profit after tax of 4.94 Crores, in the September 2025 quarter
Equity
TLL
Trident Lifeline informs about board meeting
Equity
TLL
Trident Lifeline - Quaterly Results
Equity
TLL
Trident Lifeline reports Profit after tax of 3.48 Crores, in the June 2025 quarter
Equity
TLL
Trident Lifeline - Quaterly Results
Equity
TLL
Trident Lifeline - Quaterly Results
Equity
TLL
Trident Lifeline informs about board meeting
Equity
TLL
Trident Lifeline informs about disclosure
Equity
TLL
Trident Lifeline informs about disclosure
Equity
TLL
Trident Lifeline informs about outcome of board meeting
Equity
TLL
Trident Lifeline informs about disclosure
Equity
TLL
Trident Lifeline informs about disclosure
Equity
TLL
Trident Lifeline informs about disclosure
Equity
TLL